Bloodstream infections by Malassezia and Candida species in critical care patients

Medical Mycology

Volumn 52, Issue 3, 2014, Pages 264-269

  Iatta, Roberta ^a   Cafarchia, Claudia ^a   Cuna, Teresa ^a   Montagna, Osvaldo ^b   Laforgia, Nicola ^a   Gentile, Ottavio ^b   Rizzo, Antonino ^b   Boekhout, Teun ^c,d,e   Otranto, Domenico ^a   Montagna, Maria Teresa ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

^c CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

fungal bloodstream infection; Malassezia furfur; neonates

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; RIBOSOME DNA;

ADOLESCENT; ARTICLE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDEMIA; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; EXTREMELY LOW BIRTH WEIGHT; FEMALE; FUNGEMIA; HUMAN; HUMAN TISSUE; INFANT; INTRAVASCULAR CATHETER; ITALY; MALASSEZIA FURFUR; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE PREGNANCY; NEWBORN; NEWBORN INTENSIVE CARE; NUCLEOTIDE SEQUENCE; PARENTERAL NUTRITION; PREMATURITY; PRESCHOOL CHILD; VERY LOW BIRTH WEIGHT;

FUNGAL BLOODSTREAM INFECTION; MALASSEZIA FURFUR; NEONATES;

ADOLESCENT; AMPHOTERICIN B; CANDIDA; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; DNA, FUNGAL; FEMALE; FUNGEMIA; HUMANS; INFANT; INFANT, NEWBORN; MALASSEZIA; MALE; MICROBIOLOGICAL TECHNIQUES; MOLECULAR SEQUENCE DATA; PREVALENCE; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 84898879475     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myt004     Document Type: Article

References (23)

1. Horn DL, Neofytos D, Anaissie EJ et al. Epidemiology and outcomes of candidemia in 2019 patients: Data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48: 1695-1703.
2. Bassetti M, Taramasso L, Nicco E et al. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6: E24198.
3. Caggiano G, Iatta R, Laneve A, Manca F,MontagnaMT. Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004. Mycoses 2008; 51: 123-128.
4. Pfaller M, Neofytos D, Diekema D et al. Epidemiology and outcomes of candidemia in 3648 patients: Data from the Prospective Antifungal Therapy (PATH Alliance R-) registry, 2004-2008. Diagn Microbiol Infect Dis 2012; 74: 323-331.
5. Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr 2001; 90: 323-327.
6. Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11: 142-145.
7. Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Malassezia furfur fungaemia in a neonatal patient detected by lysis-centrifugation blood culture method: First case reported in Italy. Mycoses 2011; 4: E638-640.
8. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 2012; 25: 106-141.
9. Batra R, Boekhout T, Gu?eho E et al. Malassezia Baillon, emerging clinical yeasts. FEMS Yeast Res 2005; 5: 1101-1113.
10. Zomorodain K, Mirhendi H, Tarazooie B et al. Molecular analysis of Malassezia species isolated from hospitalized neonates. Ped Dermatol 2008; 25: 312-316.
11. Cafarchia C, Dell?Aquila ME, Traversa D et al. Expression of the micro-opioid receptor on Malassezia pachydermatis and its effect in modulating phospholipase production. Med Mycol 2010; 48: 73-78.
12. Tragiannidis A, Bisping G, Koehler G, Groll AH. Minireview: Malassezia infections in immunocompromised patients. Mycoses 2010; 53: 187-195.
13. Bouza E, Mu ? noz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents 2008; 32: S87-91.
14. Cafarchia C, Gasser RB, Figueredo LA, Latrofa MS, Otranto D. Advances in the identification of Malassezia. Mol Cell Probes 2011; 25: 1-7.
15. Kolecka A, Khayhan K, Groenewald M et al. Identification of medically relevant species of arthroconidial yeasts by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2013; 51: 2491-2500.
16. Cafarchia C, Stefania Latrofa M, Testini G et al. Molecular characterization of Malassezia isolates from dogs using three distinct genetic markers in nuclear DNA. Mol Cell Probes 2007; 21: 229-238.
17. Montagna MT, Lovero G, De Giglio O et al. Invasive fungal infections in neonatal intensive care units of Southern Italy: A multicentre regional active surveillance (AURORA project). J Prev Med Hyg 2010; 51: 125-130.
18. Oguz SS, Sipahi E, Dilmen U. C-reactive protein and interleukin-6 responses for differentiating fungal and bacterial aetiology in late-onset neonatal sepsis. Mycoses 2011; 54: 212-216.
19. Carrillo-Mu ? noz AJ, Rojas F, Tur-Tur C et al. In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species. Mycoses 2013; doi:10.1111/myc.12076.
20. Marcon MJ, Powell DA. Human infections due to Malassezia spp. Clin Microbiol Rev 1992; 5: 101-119.
21. Bell LM, AlpertG, Slight PH, Campos JM. Malassezia furfur skin colonization in infancy. Infect Control Hosp Epidemiol 1988; 9: 151-153.
22. Chang HJ,Miller H, WatkinsNet al. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers pet dogs. New Engl J Med 1998; 338: 706-711.
23. Iatta R, Caggiano G, Cuna T, MontagnaMT. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia. J Chemother 2011; 23: 92-96.